Not applicableStudy completedNCT01780857What this trial is testingImmune Signature of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Baylor Research Institute 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06295692What this trial is testingJNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisWho this might be right forGeneralized Pustular PsoriasisErythrodermic Psoriasis Janssen Pharmaceutical K.K. 19
Testing effectiveness (Phase 2)Looking for participantsNCT07013201What this trial is testingA 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis LEO Pharma 135
Not applicableStudy completedNCT04459507What this trial is testingA Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in JapanWho this might be right forPalmoplantar Pustulosis Janssen Pharmaceutical K.K. 276
Testing effectiveness (Phase 2)Study completedNCT03619902What this trial is testingEvaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular PsoriasisWho this might be right forGeneralized Pustular Psoriasis Vanda Pharmaceuticals 8
Large-scale testing (Phase 3)Active Not RecruitingNCT06323356What this trial is testingTAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisWho this might be right forGeneralized Pustular PsoriasisErythrodermic Psoriasis Takeda 18
Post-approval studies (Phase 4)Study completedNCT03942042What this trial is testingIxekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic PsoriasisWho this might be right forGeneralized Pustular PsoriasisErythrodermic Psoriasis Eli Lilly and Company 12
Not applicableNot Yet RecruitingNCT06886009What this trial is testingSpesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular PsoriasisWho this might be right forGeneralized Pustular Psoriasis Boehringer Ingelheim 21
Not applicableActive Not RecruitingNCT06952465What this trial is testingA Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With PsoriasisWho this might be right forPsoriasis Bristol-Myers Squibb 2,000
Testing effectiveness (Phase 2)Study completedNCT03135548What this trial is testingInitial Dosing of BI 655130 in Palmoplantar Pustulosis PatientsWho this might be right forPsoriasis Boehringer Ingelheim 59
Testing effectiveness (Phase 2)Study completedNCT03633396What this trial is testingEvaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Vanda Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT04451720What this trial is testingStudy of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) AbbVie 119
Large-scale testing (Phase 3)Study completedNCT05352893What this trial is testingStudy to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPPWho this might be right forGeneralized Pustular Psoriasis Vanda Pharmaceuticals 45
Early research (Phase 1)Study completedNCT03972280What this trial is testingSafety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar PustulosisWho this might be right forHidradenitis SuppurativaPalmoplantar Pustulosis CSL Behring 39
Testing effectiveness (Phase 2)Study completedNCT04015518What this trial is testingTest How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) Boehringer Ingelheim 152
Testing effectiveness (Phase 2)Study completedNCT03988335What this trial is testingEvaluate RIST4721 in Palmoplantar Pustulosis (PPP)Who this might be right forPalmoplantar Pustulosis Aristea Therapeutics, Inc. 35
Not applicableNot Yet RecruitingNCT07000630What this trial is testingEfficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Peking University First Hospital 25
Not applicableLooking for participantsNCT04359394What this trial is testingInternational Rare And Severe Psoriasis Expert NetworkWho this might be right forPustular Psoriasis (PP) University Hospital, Basel, Switzerland 180
Early research (Phase 1)Active Not RecruitingNCT06433531What this trial is testingA Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)Who this might be right forGeneralized Pustular Psoriasis Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT02533375What this trial is testingStudy to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)Who this might be right forGeneralized Pustular Psoriasis (GPP)AdalimumabJapanese AbbVie 10